These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18946956)

  • 61. Preliminary results of Rh-prophylaxis during pregnancy.
    Baumgarten K; Reinold E
    Pathologica; 1972; 64(929):115-8. PubMed ID: 4210235
    [No Abstract]   [Full Text] [Related]  

  • 62. The use of Rh immune globulin: a review.
    Sutton GP; Jay A; Lim YS; Noland JE; Boral LI
    Indiana Med; 1988 Apr; 81(4):321-2. PubMed ID: 2834434
    [No Abstract]   [Full Text] [Related]  

  • 63. Genetic amniocentesis: impact of placental position upon the risk of pregnancy loss.
    Crane JP; Kopta MM
    Am J Obstet Gynecol; 1984 Dec; 150(7):813-6. PubMed ID: 6391172
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Follow-up of 2000 second-trimester amniocenteses.
    Crandall BF; Howard J; Lebherz TB; Rubinstein L; Sample WF; Sarti D
    Obstet Gynecol; 1980 Nov; 56(5):625-8. PubMed ID: 7432734
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Outcome of second trimester amniocentesis in twin pregnancies at Songklanagarind Hospital.
    Hanprasertpong T; Kor-anantakul O; Prasartwanakit V; Leetanaporn R; Suntharasaj T; Suwanrath C
    J Med Assoc Thai; 2008 Nov; 91(11):1639-43. PubMed ID: 19127782
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The scientific basis of antenatal prophylaxis.
    Urbaniak SJ
    Br J Obstet Gynaecol; 1998 Nov; 105 Suppl 18():11-8. PubMed ID: 9863973
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Risks of midtrimester amniocentesis; assessment in 3000 pregnancies.
    Leschot NJ; Verjaal M; Treffers PE
    Br J Obstet Gynaecol; 1985 Aug; 92(8):804-7. PubMed ID: 4027202
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Twin pregnancy complicated by severe hemolytic disease of the fetus and newborn due to anti-g and anti-C.
    Trevett TN; Moise KJ
    Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1178-80. PubMed ID: 16260562
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Expanded rhesus prophylaxis].
    Maroni ES
    Schweiz Rundsch Med Prax; 1987 Nov; 76(45):1254-9. PubMed ID: 2827286
    [No Abstract]   [Full Text] [Related]  

  • 70. Prenatal diagnosis in twin gestations: a comparison between second-trimester amniocentesis and first-trimester chorionic villus sampling.
    Wapner RJ; Johnson A; Davis G; Urban A; Morgan P; Jackson L
    Obstet Gynecol; 1993 Jul; 82(1):49-56. PubMed ID: 8515925
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Immunoprophylaxis with anti D immunoglobulins in Rh negative women.
    Gupta I; Jolly JG; Gupta AN
    Indian J Med Res; 1987 Jun; 85():656-8. PubMed ID: 2824352
    [No Abstract]   [Full Text] [Related]  

  • 72. Antenatal anti-D prophylaxis.
    Mitchell R; O'Donnell R; Blair RG; Blue A
    Lancet; 1980 Oct; 2(8198):798. PubMed ID: 6107471
    [No Abstract]   [Full Text] [Related]  

  • 73. Risk factors for procedure-related fetal losses after mid-trimester genetic amniocentesis.
    Kong CW; Leung TN; Leung TY; Chan LW; Sahota DS; Fung TY; Lau TK
    Prenat Diagn; 2006 Oct; 26(10):925-30. PubMed ID: 16838383
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hyporegenerative anemia in anti-M-associated hemolytic disease of the fetus.
    Li S; He Z; Mo C; Ji Y; Luo Y; Fang Q; Gao Y
    Transfusion; 2021 Jun; 61(6):1908-1915. PubMed ID: 33938570
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Midtrimester amniocentesis: is it safe? A single centre controlled prospective study of 517 consecutive amniocenteses.
    Sant-Cassia LJ; MacPherson MB; Tyack AJ
    Br J Obstet Gynaecol; 1984 Aug; 91(8):736-44. PubMed ID: 6380566
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Routine antenatal anti-D prophylaxis--is the protection adequate?
    Davies J; Chant R; Simpson S; Powell R
    Transfus Med; 2011 Dec; 21(6):421-6. PubMed ID: 21906191
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Determination of fetal RHD type in plasma of RhD negative pregnant women.
    Sørensen K; Kjeldsen-Kragh J; Husby H; Akkök ÇA
    Scand J Clin Lab Invest; 2018 Sep; 78(5):411-416. PubMed ID: 29869532
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [The importance of antenatal immunoprophylaxis for prevention of hemolytic disease of the fetus and newborn].
    Starcević M; Mataija M; Sović D; Dodig J; Matijević R; Kukuruzović M
    Acta Med Croatica; 2011 Mar; 65(1):49-54. PubMed ID: 21568074
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Efficacy and long term effects of antenatal prophylaxis with anti-D immunoglobulin.
    Thornton JG; Page C; Foote G; Arthur GR; Tovey LA; Scott JS
    BMJ; 1989 Jun; 298(6689):1671-3. PubMed ID: 2547468
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Fetal-maternal bleeding associated with genetic amniocentesis.
    Mennuti MT; Brummond W; Crombleholme WR; Schwarz RH; Arvan DA
    Obstet Gynecol; 1980 Jan; 55(1):48-54. PubMed ID: 6153239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.